COO · Cooper Companies Inc
Price
Snapshot
50 fields · last close| Market Cap | $13.78B |
| P/E | 57.71 |
| Float | 193.8M |
| Beta | 0.81 |
| Volatility | 20.4% |
| Exchange | NASDAQ |
| Sector | Health Care |
| Cap tier | Large cap |
| Macro sensitivity | Moderate |
| Clavix score | 80 |
| Price | 69.99 |
| Change | −0.92% |
| Prev Close | 70.64 |
| Open | 69.78 |
| Day Low | 69.09 |
| Day High | 70.68 |
| Avg Vol | 1 |
| Avg $ Vol | $101.8M |
| 52W High | 89.83 |
| 52W Low | 58.89 |
| 52W Pos | 35.9% |
| From High | −22.09% |
| From Low | +18.85% |
| Max DD 1Y | −30.05% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | −5.43% |
| SMA 50 | −3.68% |
| SMA 200 | −4.59% |
| RSI (14) | 40.8 |
| Vol 30D | 23.0% |
| Vol 90D | 29.7% |
| 1Y Range | 59–90 |
| Daily bars | 507 |
| Perf Week | −0.45% |
| Perf Month | −5.61% |
| Perf Quarter | +13.90% |
| Perf Half Y | −7.72% |
| Perf Year | +3.88% |
| Perf YTD | −13.71% |
| Prev Day | −0.92% |
| Clavix | A- |
| Debt / Eq | 0.50 |
| Curr Ratio | 1.89 |
| Int Cover | 5.2× |
| FCF Margin | 10.6% |
| Rev Growth | +0.1% |
| Profit | Profitable |
| Leverage | Low |
| Sector rank | 11 / 47 |
What COO does
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers.
The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia.
Its CooperSurgical segment focuses on family and women’s health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage.
This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing.
The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers.
The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Clavix risk grade
regraded every trading dayCOO grades A-, 80 of 100. Steadiest on Macro Resilience (68), most exposed on Sector Resilience (60, mixed). 3 of the 4 weighted dimensions sit above the Health Care median. Ranks 11 of 47 in Health Care by Clavix score.
How rough the ride is
| COO | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 0.81 | 0.81 |
| Volatilityannualized | 20.4% | 20.4% |
| Max drawdown, past yearworst peak-to-trough fall | −30.1% | — |
| Typical daily movemedian absolute daily change | 0.98% | — |
| Days beyond ±3%of the last 252 sessions | 218% | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| COO | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 0.81 | 0.81 |
| Macro sensitivityrate, dollar and credit exposure bucket | Moderate | Moderate55% of 47 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| COO | |
|---|---|
| 1 week | −0.5% |
| 1 month | −5.6% |
| Year to date | −13.7% |
| 1 year | +3.9% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| COO | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30since 8 Jun |
| Average score0 most bearish, 100 most bullish | 52 |
| Bullish · bearisharticles above 60 · below 40 | 10 · 7 |
| Directionarticles whose tone is improving vs worsening | 10 ↑ 7 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 47 Health Care names Clavix covers; the tick is the sector median.
Growth
| COO | |
|---|---|
| Revenue growthyear over year | +0.1% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Against Health Care
47 companies| Metric | COO | Sector spread | Median |
|---|---|---|---|
| Beta | 0.81 | 0.81 | |
| Volatility | 20.4% | 20.4% | |
| P/E | 57.71 | 26.14 | |
| Debt / equity | 0.50 | 0.71 | |
| Current ratio | 1.89 | 1.58 | |
| FCF margin | 10.6% | 8.6% | |
| Interest coverage | 5.2× | 6.3× |
Recent news
most recent scored articles · the chip is the article’s score · click to openCooper Companies (COO) reported Q2 results with 8% revenue growth, 26% growth in profit per share (excluding one-off costs), and a 2.6 percentage point improvement in profit margins, driven by a premium lens mix and restructuring. The company is also reviewing strategic options for its CooperSurgical unit, with multiple parties expressing acquisition interest and over 95% of fertility media claims now settled.
BlackRock disclosed in an SEC filing that it bought a new stake in The Cooper Companies during the second quarter, purchasing approximately 15,029,453 shares of the medical device company.
The article does not report a specific company development.
Becton Dickinson (BDX) has finished enrolling patients in its PREVENT trial for Phasix Mesh, moving the product closer to a potential FDA submission for preventing incisional hernias. The article provides no information about The Cooper Companies (COO).
Medtronic's diabetes unit MiniMed has started shipping its MiniMed Flex insulin pump in the U.S. paired with Abbott's 15-day Instinct glucose sensor, controlled through a smartphone app. The article does not name or discuss The Cooper Companies (COO).
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| BAX | Baxter International Inc | B | $13.22B | — | 0.67 | Compare |
| PEN | Penumbra Inc | A+ | $12.65B | 78.99 | 0.71 | Compare |
| BTSG | Brightspring Health Services Inc | B- | $12.15B | 32.56 | 1.86 | Compare |
| SOLV | Solventum Corp | B+ | $15.74B | 10.26 | 0.72 | Compare |
| DVA | DaVita Inc | B | $11.59B | 13.70 | 0.89 | Compare |
| ALGN | Align Technology Inc | B- | $11.36B | 27.26 | 1.73 | Compare |
| GKOS | Glaukos Corp | B- | $10.64B | — | 0.73 | Compare |
| MOH | Molina Healthcare Inc | B | $10.59B | 22.36 | 0.73 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.